Arcus Biosciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $26,000 | $48,000 | $39,000 | $145,000 |
Gross Profit | 26,000 | 48,000 | 37,000 | 142,000 |
EBITDA | -89,000 | -89,000 | -91,000 | 20,000 |
EBIT | -92,000 | -91,000 | -93,000 | 17,000 |
Net Income | -94,000 | -92,000 | -93,000 | -4,000 |
Net Change In Cash | 26,000 | 48,000 | 39,000 | 145,000 |
Free Cash Flow | -101,000 | 25,000 | -94,000 | -6,000 |
Cash | 150,000 | 201,000 | 156,000 | 185,000 |
Basic Shares | 90,100 | 91,400 | 91,100 | 86,200 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $258,000 | $117,000 | $112,000 | $382,882 |
Gross Profit | 258,000 | -223,000 | 98,000 | 375,825 |
EBITDA | -269,000 | -283,000 | -250,000 | 61,962 |
EBIT | -279,000 | -291,000 | -264,000 | 54,905 |
Net Income | -283,000 | -307,000 | -267,000 | 53,000 |
Net Change In Cash | 258,000 | 117,000 | 112,000 | 382,882 |
Cost of Revenue | -22,699 | |||
Free Cash Flow | -176,000 | -330,000 | 426,000 | -282,249 |
Cash | 150,000 | 127,000 | 206,000 | 147,914 |
Basic Shares | 90,100 | 74,000 | 72,000 | 73,966 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.03 |
2024-09-30 | -$1 |
2024-06-30 | -$1.02 |
2024-03-31 | -$0.05 |
